ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS
2 Assignments
0 Petitions
Accused Products
Abstract
Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides.
38 Citations
12 Claims
-
1. (canceled)
-
2. An oligonucleotide having the nucleotide sequence as shown in any one of SEQ ID NOS:
- 18-22, 30, 41, 64, 66, or 87 in the SEQUENCE LISTING, or a pharmacologically acceptable salt thereof.
- View Dependent Claims (3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
Specification